Tingkat Kecemasan Pasien Kanker yang Menjalani Kemoterapi di Masa Pandemi Covid-19: Literature Review

Authors

  • Liska Lihawa Program Studi DIII Keperawatan STIK Makassar
  • Ricky Zainuddin

DOI:

https://doi.org/10.36565/jab.v11i1.457

Keywords:

anxiety level, cancer, chemotherapy, covid-19 pandemic

Abstract

The high morbidity and mortality of Covid-19 causes fear and anxiety about the risk of exposure to this disease in everyone, including cancer patients. Objective: To identify the anxiety level of cancer patients undergoing chemotherapy during the Covid-19 pandemic. Methods: Article searches through Pubmed, ProQuest, ScienceDirect, Wiley, and Google Scholar identified 20,489 articles, then restricted based on inclusion criteria: a study with samples of cancer patients undergoing chemotherapy during the Covid-19 pandemic; a study that assessed the anxiety level of cancer patients undergoing chemotherapy during the Covid-19 pandemic; published in the last three years; have full text in English and Indonesian, so that 6 articles are obtained. Results: Of the six articles reviewed, one study reported that during Covid-19 all cancer patients undergoing chemotherapy experienced increased anxiety (57%); two studies reported severe anxiety (36.7%; p=0.000 and 33%); two studies reported moderate anxiety with respective scores (22.3; p=0.000; and 18.5; p=0.037); and one study of mild anxiety (25.8% women and 16.8% men; p=0.159). Anxiety experienced by patients is caused by a number of factors, including fear of being infected with Covid-19, type of cancer, age and gender, delays or changes in treatment and treatment plans, excessive exposure to information, uncertainty over the end of Covid-19, lack of understanding and information related to Covid -19, hospital restrictions, and feelings of loneliness. Conclusion: Based on the results of a review of six articles, it was concluded that cancer patients undergoing chemotherapy during the Covid-19 pandemic experienced anxiety that varied from mild to severe anxiety depending on the influencing factors

References

Ahn, M. H., Lee, J., Suh, S., Lee, S., Kim, H. J., Shin, Y. W., & Chung, S. (2020). Application of the Stress and Anxiety to Viral Epidemics-6 (SAVE-6) and Coronavirus Anxiety Scale (CAS) to Measure Anxiety in Cancer Patient in Response to Covid-19. Frontiers in Psychology, 11(6041), 1–6. https://doi.org/10.3389/fpsyg.2020.604441

Al-Quteimat, O. M., & Amer, A. M. (2020). The Impact of the COVID-19 Pandemic on Cancer Patients. American Journal of Clinical Oncology: Cancer Clinical Trials, 00(00), 1–4. https://doi.org/10.1097/COC.0000000000000712

Esen, S. A., Acikgoz, U., Yildirim, M., Ucar, G., Ergun, Y., Diriko, M., Bal, O., Algin, E., Esen, I., & Unc, D. (2021). Anxiety, Insomnia and Pandemic Awareness of Cancer Patients Receiving Chemotherapy During the COVID-19 Pandemic Period. International Journal of Hematology and Oncology, 31(2), 1–9. https://doi.org/10.4999/uhod.UHOD

Ganguly, S., Gupta, A., Arora, S., & Arora, N. (2020). Impact of Pandemics. In M. K. Goyal & A. K. Gupta (Eds.), Integrated Risk of Pandemic: Covid-19 Impacts, Resilience and Recommendations (p. 497). Springer Nature Singapore Pte Ltd. https://doi.org/https://doi.org/10.1007/978-981-15-7679-9

Hennessy, M. A., Linehan, A., Cowzer, D., Coyne, Z. L., Fitzpatrick, O., Barrett, F., Dhonaill, R. N., Hennessy, B. T., Grogan, L., Morris, P. G., & Breathnach, O. S. (2021). Chemotherapy in the Covid-19 Era: the Patient’s Perception. Irish Journal of Medical Science, 3(11), 7–12. https://doi.org/https://doi.org/10.1007/s11845-020-02457-3

Hilfiker, L., & Ganguly, S. (2020). A Review of Pandemics. In M. K. Goyal & A. K. Gupta (Eds.), Integrated Risk of Pandemic: Covid-19 Impacts, Resilience and Recommendations (p. 497). Springer Nature Singapore Pte Ltd. https://doi.org/https://doi.org/10.1007/978-981-15-7679-9

International Agency for Research on Cancer. (2021). GLOBOCAN 2020: New Global Cancer Data. International Agency for Research on Cancer (IARC). https://www.uicc.org/news/globocan-2020-new-global-cancer-data

Karacin, C., Bilgetekin, I., B Basal, F., & Oksuzoglu, O. B. (2020). How Does COVID-19 Fear and Anxiety Affect Chemotherapy Adherence in Patients with Cancer. Future Oncology, 16(29), 2283–2293. https://doi.org/10.2217/fon-2020-0592

Kemenkes RI. (2021). Covid-19. Media Informasi Terkini Penyakit Infeksi Emerging. https://infeksiemerging.kemkes.go.id/dashboard/covid-19

Kementerian Kesehatan RI. (2019). Laporan Nasional RISKESDAS 2018. Badan Penelitian dan Pengembangan Kesehatan. https://doi.org/9786023731189

Khng, J. (2021). Managing the Impact of Covid-19 on Cancer Survivors in Singapore. Asia Pacific Journal of Social Work and Development, 31(1–2), 147–151. https://doi.org/10.1080/02185385.2020.1859408

Radji, M. (2017). Mekanisme aksi Molekuler Antibiotik dan Kemoterapi (R. Nirwanto & N. Afifah, Hafshah (eds.)). EGC.

Retnaningsih, D., Auliyak, R., Mariyati, & Purnaningsih, E. (2021). Kecemasan Penderita Kanker Payudara yang Menjalani Kemoterapi Masa Pandemi Covid-19. Jurnal Ilmiah Permas: Jurnal Ilmiah STIKES Kendal, 11(1), 157–164. http://journal.stikeskendal.ac.id/index.php/PSKM

Setyani, F. A. R., Bunga, B. D., & Milliani, C. D. (2020). Tingkat Kecemasan Pasien Kanker Payudara Yang Mendapatkan Kemoterapi. Carolus Journal of Nursing, 2(2), 170–176. http://ejournal.stik-sintcarolus.ac.id/%0ATINGKAT

Shams, S., & Mansoor, K. (2020). Covid-19 and Self-Care Measures by Chemotherapy Patients. Asia-Pacific Journal of Oncology Nursing, 7(4), 310–311. https://doi.org/10.4103/apjon.apjon

Sigorski, D., Sobczuk, P., Osmola, M., Kuć, K., Walerzak, A., Wilk, M., Ciszewski, T., Kopeć, S., Hryń, K., Rutkowski, P., Stec, R., Szczylik, C., & Bodnar, L. (2020). Impact of COVID-19 on Anxiety Levels Among Patients With Cancer Actively Treated With Systemic Therapy. ESMO Open, 5(5), 1–8. https://doi.org/10.1136/esmoopen-2020-000970

Stanton, R., To, Q. G., Khalesi, S., Williams, S. L., Alley, S. J., Thwaite, T. L., Fenning, A. S., &Vandelanotte, C. (2020). Depression, Anxiety and Stress during COVID-19: Associations with Changes in Physical Activity, Sleep, Tobacco and Alcohol Use in Australian Adults. International Journal of Environmental Research and Public Health, 17(11), 1–13. https://doi.org/10.3390/ijerph17114065

Tariq, M. J., Almani, M. U., Sherazi, S. A. A., Usman, M., Arif, A. W., Yim, B., & Gupta, S. (2020). Anxiety Due to COVID-19 and Impact on Patients Receiving Chemotherapy in An Inner-City Minority Population. Journal of Clinical Oncology, 38(29), 1–9. https://doi.org/10.1200/JCO.2020.38.29_suppl.108

WHO. (2021). WHO Coronavirus (COVID-19) Dashboard. World Health Organization. https://covid19.who.int/

Yasin, A. I., Topcu, A., Shbair, A. T., Isleyen, Z. S., Ozturk, A., Besiroglu, M., & Türk, H. M. (2021). Anxiety Levels of Breast Cancer Patients in Turkey During the Covid-19 Pandemic. Future Oncology, 1–9. https://doi.org/10.2217/fon-2020-1265

Yildirim, O. A., Poyraz, K., & Erdur, E. (2021). Depression And Anxiety In Cancer Patients Before And During The Sars-Cov-2 Pandemic: Relationship With Delayed Chemotherapy. Quality of Life Research, 30(7), 1903–1912. https://doi.org/10.1007/s11136-021-02795-4

Zhang, J., Yu, H., Gao, Y., Xu, Q., Yin, Y., & Zhou, R. (2020). Prevalence of Anxiety and Depression Among Cancer Patients During the COVID-19 Pandemic: A Systematic Review and Meta-analysis Hongping. ResearchSquare, 1–12. https://doi.org/https://doi.org/10.21203/rs.3.rs-133466/v1

Downloads

Published

2022-03-30

Issue

Section

Articles